Image

Elimisha HPV (Human Papillomavirus)

Elimisha HPV (Human Papillomavirus)

Non Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This research study aims to develop a stigma-responsive educational intervention which includes simplified scripts that provide clear messages about HPV and video aimed at addressing fears and misperceptions from a peer perspective. These educational components will be incorporated into 'Elimisha' HPV a multi-level stigma-responsive cervical cancer prevention service delivery model.

Eligibility

Women attending government-supported health facilities (Aim 2)

For Aim 2, activity 4, investigators will enroll approximately 804 randomly selected women, (67 per facility in each of 12 facilities).

  • Inclusion criteria:

    *Has attended a study facility during the study period

    *Is eligible for cervical cancer screening per the Kenya Ministry of Health guidelines include: Women living with HIV (WLWH) will be between the age of 25 and 65. All other women will be between the age of 30 and 65

    • All women should have an intact uterus and cervix
  • Exclusion criteria:
    • Does not understand the study purpose and details
    • Is not willing to provide informed consent

CHVs working at government-supported health facilities (Aim 2)

Investigators will enroll approximately 36 Community Health Volunteers (CHVs) across 12 sites. CHVs will be identified by CHV supervisors and will be recruited into the study for training and participation in the stigma-responsive service delivery model at the time of randomization. Since study outcomes may appear to reflect their job performance, we will explain this as part of the informed consent and emphasize the voluntary nature of participation in the study. For both optimization of study activities and to avoid any coercion, CHVs will be able to decline participation without impact on their position in the facility.

  • Inclusion criteria:
    • Age 18 or older
    • Must be a Community Health Volunteer (CHV) at government-supported facilities in Kisumu County
  • Exclusion criteria:
    • Does not understand the study purpose and details
    • Is not willing to sign an informed consent

HIV-peer navigators (Aim 2)

Approximately 60 (10 per intervention health facility) HIV-peer navigator or a woman attending these facilities, including a woman living with HIV (WLWH).

  • Inclusion criteria:
    • Age 18 or older
    • Must have complete HPV screening and treatment in the past
    • Must be interested in getting trained as a peer navigator
  • Exclusion criteria:
    • Does not understand the study purpose and details
    • Is not willing to sign an informed consent

Aim 3 Participants

Participants will be purposively recruited from each study arm to achieve a sample with heterogeneous demographic and clinical characteristics (e.g., age, HIV and HPV status).

Women attending government-supported health facilities (Aim 3)

Investigators will enroll approximately 24 women with the option to recruit more if new themes are emerging in the IDIs.

  • Inclusion criteria:
    • Will have completed an HPV screening test at one of the intervention or control facilities
    • Agree to be audio recorded
  • Exclusion criteria:
    • Does not understand the study purpose and details
    • Is not willing to provide informed consent

Community Health Volunteers (CHVs) and Peer Navigators (Aims 3)

Investigators will enroll approximately 10 CHVs and peer navigators with the option to recruit more if new themes are emerging in the IDIs.

  • Inclusion criteria:
    • Participated as a CHV or peer navigator at one of the facilities participating in the study
    • Agree to be audio recorded
  • Exclusion criteria:
    • Does not understand the study purpose and details
    • Is not willing to sign an informed consent

Facility managers (Aim 3)

Investigators will enroll approximately 12 facility managers.

  • Inclusion criteria:
    • Age 18 or older
    • A manager at one of the facilities participating in the study
    • Agree to be audio recorded
  • Exclusion criteria:
    • Does not understand the study purpose and details
    • Is not willing to sign an informed consent

Study details
    Cervical Cancer
    HPV
    HIV
    Stigma

NCT05736588

Duke University

21 October 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.